haloperidol decanoate has been researched along with olanzapine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Becker, T; Kopf, A; Köster, J; Krömker, H; Schulz, A | 1 |
| Agrawal, SM; McCullumsmith, RE; Meador-Woodruff, JH; Stincic, TL | 1 |
| Bymaster, F; Duman, RS; Girgenti, MJ; Newton, SS; Nisenbaum, LK; Terwilliger, R | 1 |
| Bø, CN; Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R | 1 |
| Caton, M; Newman, WJ; Scangos, KW | 1 |
| De Vos, C; Decuypere, F; Denee, TR; Geerts, P; Lamotte, M; Malfait, B; Mulder, CL; Sermon, J | 1 |
2 review(s) available for haloperidol decanoate and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Life threatening neuroleptic malignant syndrome due to olanzapine].
Topics: Antipsychotic Agents; Benzodiazepines; Critical Care; Electroconvulsive Therapy; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Psychotic Disorders; Recurrence | 2003 |
5 other study(ies) available for haloperidol decanoate and olanzapine
| Article | Year |
|---|---|
Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Dyskinesia, Drug-Induced; Gene Expression; Haloperidol; In Situ Hybridization; Injections, Intramuscular; Male; Mastication; Olanzapine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; RNA, Messenger | 2003 |
Antipsychotic-induced gene regulation in multiple brain regions.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Gene Expression Profiling; Gene Expression Regulation; Haloperidol; Male; Neurotransmitter Agents; Olanzapine; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Transcription Factors | 2010 |
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Female; Haloperidol; Health Care Costs; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Models, Econometric; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Sweden | 2014 |
Multiple Long-Acting Injectable Antipsychotics for Treatment-Resistant Schizophrenia: Case Report.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Drug Therapy, Combination; Haloperidol; Humans; Injections, Intramuscular; Male; Olanzapine; Schizophrenia | 2016 |
Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.
Topics: Adult; Antipsychotic Agents; Belgium; Benzodiazepines; Delayed-Action Preparations; Drug Administration Schedule; Female; Haloperidol; Humans; Medication Adherence; Netherlands; Olanzapine; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2017 |